Financial Health Assessment — ADYEN UK LIMITED (Company No. 08051687)

Framing note: Most financial health assessments examine a working body — revenue in, costs out, cash circulating. This one is different. The patient here is not visibly ill; it is asleep. The diagnostic challenge is therefore not "is it in distress?" but "is this dormant entity being properly maintained, and does anything about it warrant attention?" Both questions turn out to have something to say.

1. Financial Health Score: C

Why a C and not an F: there are none of the classic distress symptoms — no debt burden, no negative equity, no going-concern language, no liquidation markers, no insolvency history. The balance sheet is not bleeding; it is simply static.

Why not higher: a company with no pulse, no cash of its own, and an overdue statutory filing cannot be graded as "healthy" in any meaningful operational sense. The C reflects adequate structural condition, weak maintenance.

2. Key Vital Signs

Pulse — Trading activity: absent. The company filed dormant accounts under section 480 of the Companies Act 2006 for the year ended 31 December 2024, and the XBRL tagging explicitly records EntityHasNeverTraded. In plain terms: no significant accounting transactions occurred. There is no profit and loss account to read, because there is nothing to report.

Blood pressure — Net assets: £33,897,960, unchanged from 2023. Stable, but stable in the way a parked car is stable. The figure has not moved year on year, which is exactly what you'd expect from an entity with no transactions.

Composition of the balance sheet — this is the critical finding. The entire £33.9m of "net assets" is described as "Called up share capital not paid." That is not cash in a bank account. It is a receivable — a promise from shareholders to pay for shares that has not yet been settled. In practice:

• The company holds no liquid resources of its own;
• Its solvency is entirely dependent on a shareholder obligation, not on realisable assets;
• If the capital were called, the company's financial position would change materially — but until then, the balance sheet is effectively a placeholder.

Share capital is recorded as 33,897,960 ordinary shares of £1 each. Note a small inconsistency: the underlying data tags also reference preference share classes, yet the balance sheet presents only ordinary shares. That is a presentational loose end worth tidying.

Respiration — Liabilities: nil. No creditors, no borrowings, no gearing. There is no debt to service and therefore no financial distress pathway via leverage. This is the single most reassuring vital sign.

Reflexes — Compliance: one clear miss. - Confirmation statement: OVERDUE (last made up 28 April 2025; due 12 May 2026; flagged overdue). This is the equivalent of a missed medication dose — minor in isolation, increasingly serious if ignored. Late filing penalties apply (from £150, escalating to £1,500 for repeated default), and persistent non-filing is a recognised route to compulsory strike-off. - Accounts: not overdue per the register. - Audit: exempt under s476; small companies regime applied. - PSC register: statement only. No individual or corporate PSC is registered — consistent with a group subsidiary where control sits with an overseas parent, but it should be confirmed rather than assumed.

Measurement anomaly to verify. The register records the last accounts made up to 31 December 2025 with a next due date of 30 September 2027, while the filed document is for the year ended 31 December 2024, approved by the board on 31 October 2025. That approval date sits after the normal nine-month deadline (30 September 2025). The record is not internally consistent, and it is worth confirming with the filing history whether the 2024 accounts were filed marginally late and whether a 2025 set is genuinely outstanding.

Constitution — governance. Two current Dutch directors (Xxxxxx Xxxxxxxxname shown to subscribers, Xxxxxx Xxxxxxxxname shown to subscribers) and a corporate secretary (Xxxxxxxname shown to subscribers). This is a conventional administrative profile for a UK entry in a European group structure — consistent with the Adyen group footprint at the Wells Mews, London address and the SIC code 66190 (activities auxiliary to financial intermediation).

3. Diagnosis

Primary diagnosis: dormant group entity — structurally sound, operationally inert.

This is a shell company that exists for corporate-structure reasons rather than commercial ones. It carries no debt, no trading risk and no going-concern exposure. Its balance sheet is dominated by an unfunded capital commitment rather than real resources — meaning the £33.9m headline figure overstates the company's practical financial substance considerably. Read it as "subscribed but not paid," not "£33.9m of wealth."

Secondary finding: mild compliance arrhythmia. The overdue confirmation statement is the only genuine red flag in the file. It is easily fixed, but it is the kind of thing that escalates quietly — penalties, then strike-off action, then an awkward conversation with the group.

What the numbers do not show. There is no evidence of financial distress, overtrading, creditor pressure, or insolvency risk. There is also no evidence of commercial activity. Stakeholders should not interpret the £33.9m net assets as an operating buffer or as an indicator of UK trading scale — the UK-facing website and brand presence belong to the wider group, not to this dormant entity's own accounts.

4. Recommendations

Immediate (this week) 1. File the overdue confirmation statement. Low cost, removes the only active compliance risk, and stops penalty escalation and strike-off exposure. 2. Reconcile the filing record. Establish definitively whether the 2024 accounts were filed on time, whether a 2025 accounting period is open, and correct the register discrepancy.

Short term (this quarter) 3. Confirm the dormant position remains correct. Dormancy is a factual test, not a choice. If any transactions have occurred — intercompany charges, recharges, bank interest, nominal payments — the company may no longer qualify, and dormant accounts would then be inappropriate. Re-test before the next filing. 4. Tidy the capital presentation. Reconcile the ordinary/preference share class disclosures and confirm whether the £33.9m is genuinely unpaid or has been settled and misdescribed. An unfunded capital balance of this size should be a deliberate, documented structure — not an artefact. 5. Confirm the PSC position. Verify that the "statement" entry reflects a genuine assessment of control by the overseas parent, rather than an uncompleted register.

Strategic 6. Decide the entity's purpose. A dormant company still costs money to maintain (filings, registered office, nominee secretary, director time). If it has no planned role, voluntary strike-off is cleaner and cheaper than indefinite dormancy. If it is intended to become the UK operating vehicle, plan the capitalisation properly — paid-up capital, a funded bank account, and a transition out of dormant status. 7. Watch the group dependency. With no independent cash and an unfunded shareholder receivable, this entity's financial position is entirely a function of parent support. That is acceptable for a dormant shell, but it should be understood and documented as such by anyone relying on the balance sheet.

Names of the people mentioned are shown to subscribers. See subscription